Liang C T, Barnes J, Balakir R A, Sacktor B
J Membr Biol. 1986;90(2):145-56. doi: 10.1007/BF01869932.
The in vivo and in vitro effects of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) on calcium uptake by isolated chick duodenal cells were studied. In vivo, 1,25-(OH)2D3 given orally to vitamin D-deficient chicks increased the initial rate of calcium uptake by cells prepared 1 hr after administration of the hormone. The rate was stimulated approximately 100%, 17 to 24 hr after repletion. In vitro, pre-incubation of 1,25-(OH)2D3 with cells from D-deficient chicks increased the cellular rate of calcium uptake in a concentration-dependent relationship. Enhancement was found with 10(-15) M, was maximal at 10(-13) M, and was diminished at higher (10(-11) M) concentrations. Stimulation was observed after a pre-incubation period as brief as 1 hr. The potency order for vitamin D3 analogs was 1,25-(OH)2D3 = 1-(OH)D3 greater than 25-(OH)D3 greater than 1,24,25-(OH)3D3 greater than 24,25-(OH)2D3 greater than D3. The maximal enhancement in calcium uptake induced by the analogs was the same, only the concentration at which the cell responded was different. The effectiveness of 1,25-(OH)2D3 was five orders of magnitude greater than D3. Kinetically, 1,25-(OH)2D3 increased the Vmax of calcium uptake; the affinity for calcium (Km = 0.54 mM) was unchanged. The enhanced uptake found after the cells were pre-incubated for 2 hr with the hormone was completely blocked by inhibitors of protein synthesis. 1,25-(OH)2D3, in vitro, also increased calcium uptake in cells isolated from D-replete chicks. The maximal rates of uptake were the same in cells from D-deficient and D-replete animals. The hormone had no effect on calcium efflux from cells. Calcium uptake in microvillar brush-border membrane vesicles was increased by 1,25-(OH)2D3. These findings suggest that the in vitro cell system described in this paper represents an appropriate model to examine the temporal relationships between 1,25-(OH)2D3 induction of calcium transport and specific biochemical correlates.
研究了1,25 - 二羟基维生素D3(1,25-(OH)2D3)对分离的雏鸡十二指肠细胞钙摄取的体内和体外效应。在体内,给维生素D缺乏的雏鸡口服1,25-(OH)2D3可提高在给予该激素1小时后制备的细胞的初始钙摄取速率。在补充后17至24小时,该速率大约提高了100%。在体外,将1,25-(OH)2D3与维生素D缺乏雏鸡的细胞预孵育,可使细胞钙摄取速率呈浓度依赖性增加。在10(-15) M时发现有增强作用,在10(-13) M时达到最大,在更高浓度(10(-11) M)时减弱。在短至1小时的预孵育期后就观察到了刺激作用。维生素D3类似物的效力顺序为1,25-(OH)2D3 = 1-(OH)D3大于25-(OH)D3大于1,24,25-(OH)3D3大于24,25-(OH)2D3大于D3。类似物诱导的钙摄取的最大增强作用相同,只是细胞作出反应的浓度不同。1,25-(OH)2D3的有效性比D3高五个数量级。从动力学上看,1,25-(OH)2D3增加了钙摄取的Vmax;对钙的亲和力(Km = 0.54 mM)未改变。在用该激素预孵育2小时后的细胞中发现的增强摄取被蛋白质合成抑制剂完全阻断。在体外,1,25-(OH)2D3也增加了从维生素D充足的雏鸡分离的细胞中的钙摄取。维生素D缺乏和充足的动物的细胞中的最大摄取速率相同。该激素对细胞的钙外流没有影响。1,25-(OH)2D3增加了微绒毛刷状缘膜囊泡中的钙摄取。这些发现表明,本文所述的体外细胞系统是一个合适的模型,可用于研究1,25-(OH)2D3诱导钙转运与特定生化相关物之间的时间关系。